Skip to main content
Official Website of Stem Cell Mexico – Since 2002
CALL US +1-800-646-0290
Clinical StudiesFree Consultation
Stem Cell Therapy Mexico

CLINICAL STUDIES & RESEARCH

Explore the science. Understand your options.

Clinical Studies on Stem Cell Therapy in Mexico

At Stem Cell Mexico, we help you connect research with the questions that matter to your care. Explore selected publications, see what they studied and discuss how the evidence relates to your condition.

Explore the researchTalk to Vania (opens in a new tab)

FROM A PAPER TO YOUR PLAN

What does this mean for me?

  1. Your condition

    Does the study involve people with a similar diagnosis?

  2. The treatment studied

    Do the cell source, application and procedure match?

  3. The strength of the evidence

    What changed, what did not, and what remains uncertain?

  • Original sources

    Direct links to research publications

  • Plain-language summaries

    Key findings and limitations

  • Study types identified

    Human research and preclinical work

  • Your own evaluation

    Evidence considered in clinical context

READ WITH CONTEXT

Not every study answers the same question.

  1. Preclinical

    How might it work?

    Laboratory and animal research explores mechanisms and potential effects. It does not establish results in patients.

  2. Early clinical trial

    What happens in a small group?

    Early human studies investigate safety, feasibility and possible benefit. Small samples leave important questions open.

  3. Controlled trial

    How does it compare?

    A comparison group helps separate treatment effects from other influences. Study design and follow-up still matter.

  4. Systematic review

    What does the body of research show?

    A review brings studies together. Its conclusions depend on the quality and similarity of the included research.

SELECTED PUBLICATIONS

Start with your area of interest.

This collection covers research from the wider field. These are not presented as studies conducted by Stem Cell Mexico or as proof of the Stem Cell Mexico System.

8 publications

  • Review of human trials

    Knee osteoarthritis

    9 randomized trials · 339 participants

    The analysis compared pain and function outcomes across randomized trials. Improvements were not consistent across every measure or follow-up point.

    What to keep in mind

    Different products and protocols were pooled. These results do not establish the performance of a particular clinic’s treatment.

    Clinical efficacy and safety of stem cell therapy for knee osteoarthritis: A meta-analysis

    Medicine · 2020

    Explore knee care

  • Review of human studies

    Disc-related low back pain

    8 articles · 283 cases

    The review reported improvements in pain and disability scores after cell-based treatment for discogenic low back pain.

    What to keep in mind

    The findings concern selected disc-related pain cases and studied procedures. They cannot be generalized to every cause of back pain or route of administration.

    Stem Cells Therapy as a Treatment for Discogenic Low Back Pain: A Systematic Review

    International Journal of Spine Surgery · 2025

    Explore spine care

  • Review of human studies

    Tendon disorders

    4 prospective clinical studies

    The authors reported potential improvements in pain and function in the included tendon studies.

    What to keep in mind

    Only four studies were available. Larger randomized trials and longer safety follow-up were needed. The publication also has a linked correction.

    Mesenchymal Stem Cells Use in the Treatment of Tendon Disorders: A Systematic Review and Meta-Analysis of Prospective Clinical Studies

    Annals of Rehabilitation Medicine · 2021

    Explore joint care

  • Review of human trials

    Parkinson’s disease

    11 trials · 210 participants in meta-analysis

    The analysis found preliminary signals of benefit in certain symptom measures, while the broader clinical literature showed mixed outcomes.

    What to keep in mind

    Cell sources and transplantation methods varied. Surgical adverse events and graft-induced dyskinesia were reported. Findings are not interchangeable with routine cell infusions.

    Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis

    Journal of Translational Medicine · 2023

    Explore condition information

  • Preclinical research

    Rheumatoid arthritis

    Preclinical models · not a human treatment trial

    This paper combines preclinical research on mesenchymal stromal cells in rheumatoid arthritis models.

    What to keep in mind

    Animal-model evidence can inform research questions. It cannot establish patient benefit or clinical safety in humans.

    Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis

    EBioMedicine · 2019

    Explore condition management

  • Early human trial

    Rheumatoid arthritis

    Phase I · 6 patients · 24 weeks

    Some patients improved on pain or disease-activity measures; responses were mixed. No serious adverse events were reported in this small study.

    What to keep in mind

    Six participants and short follow-up cannot establish broad effectiveness or rule out uncommon risks. The study used a specific bone-marrow-derived product.

    Allogeneic bone marrow derived clonal mesenchymal stromal cells in refractory rheumatoid arthritis: a pilot study

    Regenerative Medicine · 2024

    Explore condition management

  • Research review

    Systemic lupus erythematosus

    Review of animal and human research

    The review discusses mesenchymal and hematopoietic cell approaches, including reported disease-activity changes and immune effects.

    What to keep in mind

    It combines different cell types and settings. Infections, disease recurrence and secondary autoimmune disease are among the complications discussed.

    Stem cell-based therapy for systemic lupus erythematous

    Journal of Translational Autoimmunity · 2024

    Discuss my medical history

  • Early human trial

    Type 1 diabetes

    Phase I–II · 14 participants in interim analysis

    The study reported functioning transplanted islet cells and insulin independence in 10 of 12 full-dose recipients at one year.

    What to keep in mind

    This was a small study of a specific islet-cell product delivered into the portal vein with immunosuppression. Serious adverse events and two deaths occurred. It is not evidence for a general MSC infusion or a service offered here.

    Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes

    New England Journal of Medicine · 2025

    Discuss relevance with the clinical team

Selected references reviewed October 3, 2026. This is an educational selection, not a complete or continuously updated review. A study’s publication date is shown on each card.

CLINICAL EXPERIENCE & YOUR EVALUATION

Research informs the conversation.
Your medical history shapes it.

Dr. César Amescua provides medical direction for Stem Cell Mexico. Your treating physician evaluates your diagnosis, prior treatment and current health before recommending care.

Free ConsultationMeet Dr. Amescua

Your plan should answer:

  • Which findings are relevant to my specific condition?

  • How does the proposed treatment compare with the research?

  • What benefits, risks and alternatives should I understand?

  • How will progress and follow-up be assessed?

Explore patient safety

HEAR FROM PATIENTS

Hear the experience. Explore the evidence.

Patient stories help you understand the care experience. Published research addresses different questions about outcomes, safety and uncertainty.

View all videos on YouTube (opens in a new tab)

RESEARCH QUESTIONS

Make the science easier to navigate.

Send Vania my questions (opens in a new tab)Explore patient stories

Are these studies from your clinic?

This library includes publications from independent researchers and institutions. We do not describe them as Stem Cell Mexico studies. Any future clinic-authored publication should identify its authors, site, methods and registration where applicable.

Does a study mean the same treatment is available here?

No. Papers may involve different products, cell types, doses and routes, including specialized procedures that are not offered here. Your physician can explain what is proposed in your plan and where the evidence does or does not match.

Does a positive result guarantee that I will benefit?

No. Study results describe a group under particular conditions. Your diagnosis, health and treatment may differ. Positive findings must be considered alongside limitations, adverse events and alternatives.

Can I bring research I found online or through an AI tool?

Yes. Bring the original paper or link, along with your questions. We can help you direct those questions to the clinical team. A generated summary can miss important details about the actual treatment or participants.

Is a research publication the same as regulatory approval?

No. Publication, clinical trial registration and regulatory approval are different. Discuss the status of the specific product and intended use with your physician.

Start with what matters to you

Find your next step.

Explore an area of care, then review treatments, costs and your evaluation options.

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation